Alteration of sarcoplasmic reticulum Ca2+ release termination by ryanodine receptor sensitization and in heart

Timothy L Domeier1, Lothar A Blatter, Aleksey V Zima

  • 1Department of Molecular Biophysics and Physiology, Rush University School of Medicine, 1750 W. Harrison Street, Chicago, IL 60612, USA.

The Journal of Physiology
|September 9, 2009
PubMed

Insights

Caffeine lowers the threshold for ryanodine receptor (RyR) calcium release in heart cells, potentially enhancing cardiac contractility. This study reveals a new mechanism for regulating calcium release during excitation-contraction coupling.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Physiology

Background:

  • The ryanodine receptor (RyR) is crucial for cardiac excitation-contraction coupling (ECC).
  • How RyR modulation affects ECC is not fully understood.
  • Caffeine is known to modulate RyR activity.

Purpose of the Study:

  • To investigate the functional effects of low-dose caffeine on RyR-mediated SR Ca(2+) release during cardiac ECC.
  • To determine if caffeine alters the termination of local Ca(2+) release.
  • To examine RyR function in failing hearts.

Main Methods:

  • Dynamic measurements of cytosolic Ca(2+) ([Ca(2+)](i)) and sarcoplasmic reticulum (SR) Ca(2+) ([Ca(2+)](SR)) in rabbit ventricular myocytes.
  • Field stimulation at 1 Hz and application of 250 microM caffeine.
  • Measurement of spontaneous Ca(2+) sparks in permeabilized myocytes.
  • Comparison of RyR function in myocytes from failing and non-failing hearts.

Main Results:

  • 250 microM caffeine initially increased SR Ca(2+) release by 33% but decreased SR Ca(2+) load and steady-state release.
  • Caffeine decreased the [Ca(2+)](SR) termination level for local Ca(2+) release by 21% during ECC and 12% during Ca(2+) sparks.
  • Myocytes from failing hearts showed a 13% lower [Ca(2+)](SR) termination level for Ca(2+) sparks.

Conclusions:

  • Altering the termination level of local Ca(2+) release is a novel mechanism to increase SR Ca(2+) release.
  • This mechanism may enhance cardiac contractility during ECC.
  • RyR function, specifically Ca(2+) release termination, is altered in heart failure.

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Relaxation of Skeletal Muscles01:29

Relaxation of Skeletal Muscles

The period of muscle contraction primarily influences the duration of stimulation at the neuromuscular junction (NMJ), the presence of free calcium ions in the sarcoplasm, and the availability of energy or ATP to support contractions.
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open.
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...